{"id":"85de5a2b-fe1d-436b-b076-273d767281b3","modelId":"0216a754-b343-4bc3-9cb6-04b378e0cbf0","versionId":null,"locationId":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","operatorId":"b01ea9e1-7eb2-41ff-87ea-632d986c63bf","ownerId":null,"slug":"sentante-endovascular-platform-germany-europe","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["surgical_assistance","microsurgery","precision_manipulation"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"small_2_10","siteEnvironment":"indoor","operatorType":"customer_deployed","sourceQualityTier":8,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[],"notes":"Commercial product — available for purchase in this market.","keyFacts":[],"reviewNote":"Bulk deepened — form-factor-based metadata assignment","exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-20T04:09:14.726Z","updatedAt":"2026-08-20T16:28:01.505Z","model":{"id":"0216a754-b343-4bc3-9cb6-04b378e0cbf0","companyId":"b01ea9e1-7eb2-41ff-87ea-632d986c63bf","modelName":"Sentante Endovascular Robotic Platform","slug":"sentante-endovascular-platform","description":"CE-marked endovascular robotic platform with haptic force feedback for remote vascular interventions.","formFactor":"surgical","industryVertical":"healthcare","environment":"indoor","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.medtechdive.com/news/sentante-lands-europes-ce-mark-for-endovascular-robot/820918/","title":"Sentante lands Europe's CE mark for endovascular robot","sourceName":"MedTech Dive"},{"url":"https://sentante.com/product/","title":"Sentante Robotic System for Endovascular Interventions","sourceName":"Sentante"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form Factor","value":"surgical"},{"label":"Maturity","value":"commercial"},{"label":"Endovascular intervention scope","value":"Sentante says its robotic system can support peripheral vascular, neurovascular, cardiovascular and electrophysiology interventions while using standard guidewires and catheter-based devices ([Sentante robotic system](https://sentante.com/product/)).","sourceUrl":"https://sentante.com/product/"},{"label":"Remote haptic control","value":"Sentante describes a remote workstation, a robotic bedside unit and tactile resistance feedback that mirrors physician hand movements for guidewire and catheter control ([Sentante robotic system](https://sentante.com/product/)).","sourceUrl":"https://sentante.com/product/"},{"label":"Sentante page prints three devices and .014 to .035 inch wires","value":"Sentante's product page prints control of up to three devices at once, including guidewires from .014 inch to .035 inch. The stored intervention-scope sentence is not this wire-size cell ([Sentante](https://sentante.com/product/))."},{"label":"Sentante page prints catheters from 2Fr to 8Fr","value":"The same page prints catheters from 2Fr to 8Fr on standard off-the-shelf devices, with no proprietary instruments required. That cell is not the stored haptic-workstation sentence ([Sentante](https://sentante.com/product/))."}],"createdAt":"2026-08-08T22:30:18.354Z","updatedAt":"2026-10-04T02:55:37.081Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"b01ea9e1-7eb2-41ff-87ea-632d986c63bf","name":"Sentante","slug":"sentante","description":"Sentante is a Vilnius-based medical robotics company developing an endovascular robotic platform with haptic force feedback and real-time guidance for remote vascular interventions. The first endovascular robot to complete an entire procedure in a clinical trial (ESSENTIAL, NCT06537947). Backed by €6M seed funding from Practica Capital and EIC Fund.","status":"private","founded":0,"hq":"Vilnius, Lithuania","hqLat":54.6870458,"hqLng":25.2829111,"hqGeocodedAt":"2026-08-23T21:07:25.171Z","hqAddress":null,"hqPrecision":null,"website":"sentante.com","fundingTotal":"6500000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.medtechdive.com/news/sentante-lands-europes-ce-mark-for-endovascular-robot/820918/","title":"Sentante lands Europe's CE mark for endovascular robot","sourceName":"MedTech Dive"},{"url":"https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/","date":"2026-05-20","title":"Sentante Receives CE Mark Approval unlocking commercialisation of its Endovascular Robotic platform","sourceName":"Sentante"}],"keyFacts":[{"label":"CE Mark","value":"May 2026"},{"label":"Product","value":"Endovascular Robotic Platform"},{"label":"CE mark commercialisation (primary Sentante)","value":"Sentante's May 20 2026 release says it secured CE mark approval for its flagship endovascular robotic platform, enabling marketing and sales of the multi-domain robotic platform across European markets. CEO and co-founder Edvardas Satkauskas is quoted on moving into commercialisation; co-founder Dr. Tomas Baltrunas is quoted on scaling. Next steps listed are initial market rollout, clinician training, and commercial footprint expansion ([Sentante](https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/))","sourceUrl":"https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/"},{"label":"Platform positioning (primary Sentante)","value":"The about blurb on the same page says Sentante was founded in 2017 and builds a haptic, device-agnostic endovascular platform for remote vascular procedures with tactile feedback, designed to integrate with existing cath-lab infrastructure across peripheral vascular, neurovascular, and cardiovascular applications. It also notes a recently unveiled digital indeflator for angioplasty and stent deployment ([Sentante](https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/))","sourceUrl":"https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:30:17.976Z","updatedAt":"2026-09-29T18:34:11.576Z"}},"version":null,"location":{"id":"f42cb087-b4c0-49ea-97b6-d47fcfa6f304","name":"Germany, Europe","slug":"germany-europe","kind":"country","parentLocationId":null,"region":"Western Europe","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-20T04:07:01.358Z","updatedAt":"2026-08-21T03:20:12.226Z"},"operator":{"id":"b01ea9e1-7eb2-41ff-87ea-632d986c63bf","name":"Sentante","slug":"sentante","description":"Sentante is a Vilnius-based medical robotics company developing an endovascular robotic platform with haptic force feedback and real-time guidance for remote vascular interventions. The first endovascular robot to complete an entire procedure in a clinical trial (ESSENTIAL, NCT06537947). Backed by €6M seed funding from Practica Capital and EIC Fund.","status":"private","founded":0,"hq":"Vilnius, Lithuania","hqLat":54.6870458,"hqLng":25.2829111,"hqGeocodedAt":"2026-08-23T21:07:25.171Z","hqAddress":null,"hqPrecision":null,"website":"sentante.com","fundingTotal":"6500000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.medtechdive.com/news/sentante-lands-europes-ce-mark-for-endovascular-robot/820918/","title":"Sentante lands Europe's CE mark for endovascular robot","sourceName":"MedTech Dive"},{"url":"https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/","date":"2026-05-20","title":"Sentante Receives CE Mark Approval unlocking commercialisation of its Endovascular Robotic platform","sourceName":"Sentante"}],"keyFacts":[{"label":"CE Mark","value":"May 2026"},{"label":"Product","value":"Endovascular Robotic Platform"},{"label":"CE mark commercialisation (primary Sentante)","value":"Sentante's May 20 2026 release says it secured CE mark approval for its flagship endovascular robotic platform, enabling marketing and sales of the multi-domain robotic platform across European markets. CEO and co-founder Edvardas Satkauskas is quoted on moving into commercialisation; co-founder Dr. Tomas Baltrunas is quoted on scaling. Next steps listed are initial market rollout, clinician training, and commercial footprint expansion ([Sentante](https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/))","sourceUrl":"https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/"},{"label":"Platform positioning (primary Sentante)","value":"The about blurb on the same page says Sentante was founded in 2017 and builds a haptic, device-agnostic endovascular platform for remote vascular procedures with tactile feedback, designed to integrate with existing cath-lab infrastructure across peripheral vascular, neurovascular, and cardiovascular applications. It also notes a recently unveiled digital indeflator for angioplasty and stent deployment ([Sentante](https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/))","sourceUrl":"https://sentante.com/news/sentante-receives-ce-mark-approval-unlocking-commercialisation-of-its-endovascular-robotic-platform/"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:30:17.976Z","updatedAt":"2026-09-29T18:34:11.576Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/sentante-endovascular-platform-germany-europe","url":"https://registry.deploy.report/deployments/sentante-endovascular-platform-germany-europe","name":"Sentante Endovascular Robotic Platform at Germany, Europe","identifier":"85de5a2b-fe1d-436b-b076-273d767281b3","startDate":"2024-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/germany-europe","name":"Germany, Europe"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/sentante","name":"Sentante"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/sentante-endovascular-platform","name":"Sentante Endovascular Robotic Platform"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"claimed-not-verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"surgical","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}